Richard Oparil is a principal of Porzio, Bromberg & Newman and a member of the firm’s Intellectual Property and Litigation Departments. He has 30 years of experience representing clients before federal courts, agencies and Congress.

Richard has represented biotechnology, life sciences, dietary supplement, medical device, pharmaceutical, defense, financial services, software and other companies in patent, trademark, unfair competition, trade secrets, trade regulation and other complex litigation at the trial and appellate levels and before the International Trade Commission. He has extensive experience in technology licensing, counseling and due diligence matters. Richard is also actively engaged in regulatory issues at the Federal Trade Commission and Food and Drug Administration. His clients have ranged in size from the Fortune 500 to startups.

His practice also includes representing individuals and companies in white collar crime cases, including grand jury, Congressional and internal investigations. He has represented a variety of targets or subjects of investigations by the Department of Justice, including the then-Chairman of Enron Corporation. Richard represented a member of the International Olympic Committee at Congressional oversight hearings involving the selection of bid cities. He also represented clients in campaign finance investigations conducted by the Department of Justice and Congressional Committees. He regularly represented defendants in civil qui tam actions under the False Claims Act.

Richard has served as a sole or panel arbitrator in dozens of cases. He is a former member of the DC Attorney/Client Arbitration Board and has previously served as co-chair of the DC Bar’s Litigation Section. He currently serves as a mediator for the U.S. District Court for the District of Columbia. A Martindale-Hubbell AV-rated attorney, he was recognized in ALM’s 2013 “Legal Leaders: Washington DC and Baltimore Top Rated Lawyers.”